China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE0000011K8
CNY
28.23
-0.03 (-0.11%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
27,321.83
24,464.05
17,872.41
15,339.95
13,461.68
14,587.56
13,209.79
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
27,321.83
24,464.05
17,872.41
15,339.95
13,461.68
14,587.56
13,209.79
Raw Material Cost
13,629.02
11,859.69
8,481.55
6,508.58
5,253.91
5,004.19
4,290.83
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
84.07
85.17
22.74
16.53
6.89
6.36
27.88
Selling and Distribution Expenses
8,728.57
8,330.62
6,021.91
5,877.20
5,839.12
7,461.14
7,058.24
Other Expenses
62.76
55.63
52.03
51.24
42.35
40.50
30.36
Total Expenditure (Excl Depreciation)
23,069.30
20,831.83
15,046.48
12,914.74
11,523.42
12,876.73
11,680.52
Operating Profit (PBDIT) excl Other Income
4252.5
3632.2000000000003
2825.8999999999996
2425.2000000000003
1938.3000000000002
1710.8000000000002
1529.3000000000002
Other Income
472.17
394.15
275.44
285.39
328.46
1,047.70
228.98
Operating Profit (PBDIT)
5,581.81
4,771.91
3,626.71
3,024.88
2,658.46
3,089.62
2,111.17
Interest
84.07
85.17
22.74
16.53
6.89
6.36
27.88
Exceptional Items
6.16
-83.77
-75.00
-39.95
-165.46
-158.12
12.16
Gross Profit (PBDT)
13,692.81
12,604.36
9,390.86
8,831.37
8,207.77
9,583.37
8,918.95
Depreciation
900.26
853.71
571.41
524.58
426.72
369.80
376.25
Profit Before Tax
4,603.65
3,749.25
2,957.56
2,443.82
2,059.39
2,555.34
1,719.20
Tax
815.87
580.97
466.43
345.41
441.89
429.55
244.01
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
3,367.89
2,852.93
2,448.80
2,055.10
1,597.49
2,098.85
1,432.08
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
3,367.89
2,852.93
2,448.80
2,055.10
1,597.49
2,098.85
1,432.08
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
409.85
320.55
48.21
43.49
20.04
26.59
42.79
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
3,777.74
3,173.48
2,497.01
2,098.59
1,617.53
2,125.44
1,474.87
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
19,903.11
18,967.14
17,009.63
15,313.19
13,727.09
12,760.12
10,827.72
Earnings per share (EPS)
2.03
1.72
1.48
1.24
0.97
1.27
0.87
Diluted Earnings per share
2.03
1.72
1.48
1.24
0.97
1.27
0.87
Operating Profit Margin (Excl OI)
15.41%
14.41%
15.55%
14.44%
14.14%
11.46%
11.4%
Gross Profit Margin
20.14%
18.82%
19.75%
19.35%
18.47%
20.05%
15.86%
PAT Margin
12.33%
11.66%
13.7%
13.4%
11.87%
14.39%
10.84%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2024 is 11.68% vs 36.88% in Dec 2023

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2024 is 19.04% vs 27.09% in Dec 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2024 is 16.72% vs 30.63% in Dec 2023

stock-summary

Interest

YoY Growth in year ended Dec 2024 is -1.29% vs 275.33% in Dec 2023

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2024 has improved from Dec 2023

Compare Annual Results Of China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
27,321.83
0
27,321.83
Other Operating Income
0.00
0.00
0.00
Total Operating income
27,321.83
0
27,321.83
Raw Material Cost
13,629.02
0
13,629.02
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
84.07
0
84.07
Selling and Distribution Expenses
8,728.57
0
8,728.57
Other Expenses
62.76
0.00
62.76
Total Expenditure (Excl Depreciation)
23,069.30
0
23,069.30
Operating Profit (PBDIT) excl Other Income
4,252.52
0.00
4,252.52
Other Income
472.17
0
472.17
Operating Profit (PBDIT)
5,581.81
0
5,581.81
Interest
84.07
0
84.07
Exceptional Items
6.16
0
6.16
Gross Profit (PBDT)
13,692.81
0
13,692.81
Depreciation
900.26
0
900.26
Profit Before Tax
4,603.65
0
4,603.65
Tax
815.87
0
815.87
Provisions and contingencies
0
0
0.00
Profit After Tax
3,367.89
0
3,367.89
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
3,367.89
0
3,367.89
Share in Profit of Associates
0
0
0.00
Minority Interest
409.85
0
409.85
Other related items
0.00
0.00
0.00
Consolidated Net Profit
3,777.74
0
3,777.74
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
19,903.11
0
19,903.11
Earnings per share (EPS)
2.03
0
2.03
Diluted Earnings per share
2.03
0
2.03
Operating Profit Margin (Excl OI)
15.41%
0%
0.00
15.41%
Gross Profit Margin
20.14%
0%
0.00
20.14%
PAT Margin
12.33%
0%
0.00
12.33%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 2,732.18 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 11.68% vs 36.88% in Dec 2023

Annual - Consolidate Net Profit
Consolidate Net Profit 377.77 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 19.04% vs 27.09% in Dec 2023

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 510.96 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 16.72% vs 30.63% in Dec 2023

Annual - Interest
Interest 8.41 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -1.29% vs 275.33% in Dec 2023

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 15.41%
in Dec 2024

Figures in %
stock-summary

YoY Growth in year ended Dec 2024 has improved from Dec 2023